Search results
Why Shares of Fresenius Medical Care Were Dropping on Wednesday
Motley Fool· 8 months agoWhat happened Shares of Fresenius Medical Care (NYSE: FMS) were down more than 18% as of noon ET on...
Why Shares of Structure Therapeutics Are Soaring on Friday
Motley Fool· 8 months agoWhat happened Shares of Structure Therapeutics (NASDAQ: GPCR) were up by more than 32% as of 12:15...
Why Shares of CureVac Jumped This Week
Motley Fool· 11 months agoWhat happened Shares of CureVac (NASDAQ: CVAC) were up by 14.3% for the week as of Friday morning, after having been up by as much as 16%, according to...
Why Shares of Tango Therapeutics Are Dropping Monday
Motley Fool· 8 months agoWhat happened Shares of Tango Therapeutics (NASDAQ: TNGX) were down more than 12% as of 11:15 a.m. on Monday. The healthcare stock is up more than 37%...
Why Shares of Koninklijke Philips Are Falling on Friday
Motley Fool· 8 months agoWhat happened Shares of medical technology company Koninklijke Philips (NYSE: PHG) were down more...
Why Shares of Ambrx Biopharma Fell Tuesday
Motley Fool· 1 year agoWhat happened Shares of Ambrx BioPharma (NYSE: AMAM) fell 28.1% for the day as of late Tuesday afternoon. The clinical-stage biotech announced Monday...
Why Shares of TG Therapeutics Soared on Tuesday
Motley Fool· 1 year agoWhat happened Shares of TG Therapeutics (NASDAQ: TGTX) were up by 18% as of mid-afternoon Tuesday after reports that the biotech's multiple sclerosis...
Why Shares of Mesoblast Are Down Monday
Motley Fool· 10 months agoWhat happened Shares of Mesoblast (NASDAQ: MESO) were down by more than 15% as of 11:45 a.m. ET on Monday, just days after the healthcare stock plunged...
Why Shares of Cassava Sciences Jumped This Week
Motley Fool· 1 year agoWhat happened Shares of Cassava Sciences (NASDAQ: SAVA) were up 18.7% for the week, according to data provided by S&P Global Market Intelligence. The...
Why Intra-Cellular Therapies Climbed Tuesday
Motley Fool· 1 year agoWhat happened Shares of Intra-Cellular Therapeutics (NASDAQ: ITCI) were up 14.8% Tuesday morning after the healthcare company released top-line phase 3...